Sanofi to Buy Rare-Disease Assets From Inhibrx 0 23.01.2024 13:39 The Wall Street Journal Sanofi plans to buy assets from U.S. biopharmaceutical company Inhibrx in a deal valued at up to $2.2 billion. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
